EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Comparative Study of Metoprolol and Amlodipine on Mortality, Disability and Complication in Acute Stroke

Jayantee Kalita, Dhiraj Kumar, Nagendra B Gutti, Sandeep K Gupta, Anadi Mishra, Vivek Singh

Journal of Neuroscience and Neurological Disorders · 04.04.2025 · 9 (1) · 039-045

DOI: 10.29328/journal.jnnd.1001108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroscience and Neurological Disorders, online erschienen am 04.04.2025. Verfasst von Jayantee Kalita und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stress in acute stroke may increase mortality and complications, but there is a paucity of information on the efficacy of beta blockers over other anti-hypertensive. To report efficacy of metoprolol over amlodipine in reducing mortality, disability and infections in acute stroke. CT/MRI confirmed stroke patients within 3 days of onset were included whose age was 18 to 75 years. Patients with secondary intracerebral hemorrhage, organ failure, pregnancy, malignancy, and immunosuppressant or on beta-blocker/amlodipine were excluded. Stroke risk factors, Glasgow Coma Scale (GCS) score, National Institute of Health Stroke Scale (NIHSS) score and CT/MRI findings were noted. Patients with a blood pressure of > 160/90 mm of Hg were randomized using 1:1 randomization to metoprolol (25 mg on day 1, 50 mg if BP is not controlled) or amlodipine (2.5 mg on day 1, then 5 mg then 10 mg on, subsequent days if BP is not controlled). Other standard treatment was continued. The primary outcome was mortality at 1 month; secondary outcomes included were in-hospital gastrointestinal hemorrhage, pneumonia, sepsis and 3 months functional outcome based on modified Rankin Scale (mRS). Side effects were noted. 18 (14.4%) patients died; 6 (9.7%) in metoprolol and 12 (19%) in amlodipine (p = 0.20) group. At 3-months, 66 patients had good outcome; 45 (80.4%) in metoprolol and 21 (43.3%) in amlodipine group (p < 0.001). The other secondary outcomes were comparable between the two groups. Metoprolol was withdrawn in 6 patients due to bradycardia, and amlodipine in 5 due to hypotension and in 1 due to allergic reaction. Metoprolol is associated with improved functional outcomes in acute stroke compared to amlodipine.

Zitieren

APA

Kalita, J., Kumar, D., Gutti, N. B., Gupta, S. K., Mishra, A., & Singh, V. (2025). A Comparative Study of Metoprolol and Amlodipine on Mortality, Disability and Complication in Acute Stroke. Journal of Neuroscience and Neurological Disorders, 9(1), 039-045. https://doi.org/10.29328/journal.jnnd.1001108

Vancouver

Kalita J, Kumar D, Gutti NB, Gupta SK, Mishra A, Singh V. A Comparative Study of Metoprolol and Amlodipine on Mortality, Disability and Complication in Acute Stroke. Journal of Neuroscience and Neurological Disorders. 2025;9(1):039-045. doi:10.29328/journal.jnnd.1001108

BibTeX
@article{Kalita2025,
  author = {Kalita, Jayantee and Kumar, Dhiraj and Gutti, Nagendra B and Gupta, Sandeep K and Mishra, Anadi and Singh, Vivek},
  title = {A Comparative Study of Metoprolol and Amlodipine on Mortality, Disability and Complication in Acute Stroke},
  journal = {Journal of Neuroscience and Neurological Disorders},
  year = {2025},
  volume = {9},
  number = {1},
  pages = {039--045},
  doi = {10.29328/journal.jnnd.1001108}
}
Kostenlos starten →